Raghu Ram Salvu Raju
Analyst, HC Wainwright & Co.
Replay available
Addex Therapeutics Ltd (ADXN) Q2 2026 Earnings Call
Addex Therapeutics Ltd (NASDAQ: ADXN) reported Q2 2026 results on this call. Replay available.
Investor webinar replay
Latest press releases
- SIX:ADXN — Addex Therapeutics Announces Executive Management Changes · Fri, Oct 2, 2026
- SIX:ADXN — Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update · Mon, Sep 28, 2026
Companies on this event
Featured Presenters
Misha Kalinichev
Head of Translational Science
Tim Dyer
CEO, Addicts Therapeutics
More from Addex Therapeutics Ltd
- Sep 28, 2026 Addex Therapeutics Ltd (ADXN) Q2 2026 Earnings Call
- Jun 25, 2026 Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call
- Apr 30, 2026 Addex Therapeutics Ltd (ADXN) Q4 2025 Earnings Call
- Dec 04, 2025 Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call
- Oct 01, 2025 Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call
- Jun 19, 2025 Addex Therapeutics Ltd (ADXN) Q1 2025 Earnings Call